MFDS
- Status: likely_approved
🇰🇷 Optiray 320 in South Korea
Optiray 320 (IOVERSOL) regulatory status in South Korea.
Marketing authorisation
Optiray 320 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in South Korea
Frequently asked questions
Is Optiray 320 approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Optiray 320 in South Korea?
Liebel-Flarsheim is the originator. The local marketing authorisation holder may differ — check the official source linked above.